APA (7th ed.) Citation

Kleinbongard, P., Bøtker, H. E., Ovize, M., Hausenloy, D. J., & Heusch, G. (2020). Co‐morbidities and co‐medications as confounders of cardioprotection—Does it matter in the clinical setting? British Journal of Pharmacology, 177(23), 5252. https://doi.org/10.1111/bph.14839

Chicago Style (17th ed.) Citation

Kleinbongard, Petra, Hans Erik Bøtker, Michel Ovize, Derek J. Hausenloy, and Gerd Heusch. "Co‐morbidities and Co‐medications as Confounders of Cardioprotection—Does It Matter in the Clinical Setting?" British Journal of Pharmacology 177, no. 23 (2020): 5252. https://doi.org/10.1111/bph.14839.

MLA (9th ed.) Citation

Kleinbongard, Petra, et al. "Co‐morbidities and Co‐medications as Confounders of Cardioprotection—Does It Matter in the Clinical Setting?" British Journal of Pharmacology, vol. 177, no. 23, 2020, p. 5252, https://doi.org/10.1111/bph.14839.